Phase 3 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part voluntarily and sign a consent form
- You are between 18 and 80 years old (male or female)
- You have been diagnosed with a specific type of kidney cancer called clear cell renal cell carcinoma, confirmed through a tissue sample test
- Your cancer has been classified at a certain stage based on CT or MRI scans, indicating it is locally advanced but has not spread to distant parts of the body (confirm with trial site for exact staging details)
- You are generally able to carry out daily activities with little to no limitation (as measured by a standard health scoring tool used by doctors)
- Your heart, bone marrow, liver, and kidneys are working well enough, as shown by recent blood and organ function tests
Who may not be able to join:
- Your cancer has spread to distant parts of the body (for example, lungs, bones, or other organs)
- You have serious liver or kidney problems, or other significant health conditions alongside your cancer
- You have had a heart attack, inflammation of the arteries, or a blood clot (such as a pulmonary embolism) within the past year
- You have severe or unstable chest pain (angina), or high blood pressure that cannot be controlled with treatment
- You have been diagnosed with serious heart failure (classified as Class III or IV by your heart doctor)
- You have an irregular heartbeat that requires medication to manage
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fangjian Zhou, Professor, Director of Dept. of Urology, Sun Yat-sen University Cancer Center
Phone: +86-020-87343860
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
disease-free survival (DFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.